arrow
M

Megumi Murakami

national institutes of health
H指数:12
被引数:416

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Erratum to “The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs” [European Journal of Pharmaceutical Sciences (2025) 107337]

勘误:“第四代EGFR酪氨酸激酶抑制剂BLU-945使ABCG2过表达的耐多药非小细胞肺癌细胞对细胞毒性抗癌药物重新敏感”〔European Journal of Pharmaceutical Sciences (2025) 107337〕

2025-12-040
OAAI
Structure-activity relationship studies on 2-thienylidene substituted 3-oxo-2,3-dihydrobenzofuran-7-carboxamides as poly (ADP-ribose) polymerase inhibitors

2-噻吩基取代的3-氧代-2,3-二氢苯并呋喃-7-甲酰胺类化合物的构效关系研究,作为聚(ADP-核糖)聚合酶抑制剂

2025-09-050
PRE
Reserpine analog modulates transport function of ABCG2
2024-03-220
PRE